Immunovant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.

About IMVT

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. 

CEO
Peter Salzmann
CEOPeter Salzmann
Employees
164
Employees164
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2018
Founded2018
Employees
164
Employees164

IMVT Key Statistics

Market cap
4.86B
Market cap4.86B
Price-Earnings ratio
-17.67
Price-Earnings ratio-17.67
Dividend yield
Dividend yield
Average volume
1.37M
Average volume1.37M
High today
$32.95
High today$32.95
Low today
$31.55
Low today$31.55
Open price
$32.81
Open price$32.81
Volume
1.20M
Volume1.20M
52 Week high
$45.58
52 Week high$45.58
52 Week low
$14.05
52 Week low$14.05

Analyst ratings

100%

of 18 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.